4th vaccine: Novavax shot 96% effective against original coronavirus in UK trial
LONDON - Novavax Inc's COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdo…
